Table 2.
Variable | All N = 64 | Male N = 34 | Female N = 30 | P value |
---|---|---|---|---|
Stroke Onset | ||||
In-hospital¶ | 28 (44) | 17 (50) | 11 (37) | 0.22 |
In the community¶ | 34 (53) | 16 (47) | 18 (60) | 0.22 |
Cannot be determined¶ | 2 (3) | 1 (3) | 1 (3) | 0.99 |
Symptomatic stroke¶ | 46 (72) | 24 (71) | 22 (73) | 0.81 |
Incidentally found¶ | 18 (28) | 10 (29) | 8 (27) | 0.81 |
LKW to symptom discovery, days* | 0.4 (1.6) | 0.4 (1.7) | 0.5 (1.1) | 0.78 |
LKW to hospital presentation, days* | 0.6 (2.6) | 0.5 (1.7) | 1.0 (3.1) | 0.16 |
NIHSS at admission* | 8 (21) | 10 (18) | 4 (12) | 0.08 |
Location | ||||
Cortical¶ | 39 (61) | 22 (65) | 17 (57) | 0.41 |
Subcortical, supratentorial¶ | 5 (8) | 3 (9) | 2 (7) | 0.42 |
Infratentorial¶ | 5 (8) | 0 | 5 (17) | 0.02 |
Mixed¶ | 15 (23) | 9 (26) | 6 (20) | 0.57 |
Mechanism | ||||
Cryptogenic¶ | 25 (39) | 10 (23) | 15 (38) | 0.20 |
Large-artery atherosclerosis¶ | 7 (11) | 3 (7) | 4 (10) | 0.69 |
Cardioembolism¶ | 17 (27) | 11 (25) | 6 (15) | 0.25 |
Lacunar¶ | 6 (9) | 4 (9) | 2 (5) | 0.99 |
Stroke of other determined etiology¶ | 8 (9) | 5 (11) | 3 (8) | 0.71 |
Treatment | ||||
Tissue plasminogen activator¶ | 5 (8) | 3 (7) | 2 (5) | 0.75 |
Mechanical thrombectomy¶ | 7 (11) | 4 (9) | 3 (8) | 0.82 |
Disposition | ||||
Home¶ | 14 (22) | 4 (12) | 10 (33) | 0.04 |
Acute Rehabilitation¶ | 16 (25) | 8 (24) | 8 (27) | 0.78 |
Other¶§ | 16 (25) | 9 (26) | 7 (23) | 0.77 |
Death¶ | 17 (27) | 13 (38) | 4 (13) | 0.02 |
mRS (all patients) * | 4.0 (3.0) | 5.0 (2.0) | 4.0 (3.0) | 0.02 |
mRS (survivors)* | 4.0 (2.0) | 4.0 (2.0) | 3.5 (3.0) | 0.03 |
LKW: last known well; mRS: modified Rankin Scale; NIHSS: National Institute of Health Stroke Scale.
n (%).
median (IQR).
Includes skilled nursing facility, long-term acute care hospitals, and hospice.